Jan 22, 2009 09:30 ET
BioTech Medics, Inc. Announces Opening of Fifth Pain Management Center
Highlighted Links
biotechmedics.com
DALLAS, TX--(Marketwire - January 22, 2009) - BioTech Medics, Inc. (PINKSHEETS: BMCS) announced the opening of their fifth affiliated BioTech L3aser™ Center at Life Vessel Advanced Wellness Center of Newport Beach, California. This is the international headquarters of Life Vessel. Life Vessel is overseen by Darrel E. Hopkins, D.O. and Todd Strane, Managing Director.
Life Vessel of Newport Beach, California and Life Vessel of Santa Fe, New Mexico offers the exclusive and proprietary BioTech L3aser™ Pain Management Treatment Protocols using an FDA 510(k) cleared high-powered deep penetrating medical therapeutic laser. The medical laser is a proven, quick, safe, effective non-invasive medical device. Persons with back pain, carpal tunnel, knee pain, arthritis or 90 other muscular, skeletal or nerve pain ailments can be treated in any one of BioTech's five pain centers nationwide. The remaining BioTech L3aser™ Pain Management and Wellness Centers are located in Dallas, Texas; Kansas City (Overland Park), Kansas and Albuquerque, New Mexico. A sixth center is estimated to open in San Diego this Summer.
Unlike, "cold lasers," BioTech's high-powered lasers are patent protected with up to 10,000 times more power than most "cold lasers." Patients feel the soothing high-powered laser as they are being treated over their area of pain.
Additional BioTech affiliated centers are available in the USA. Investors interested in becoming a part of the BioTech affiliated centers should phone the BioTech Investor Relations or email the company at: info@biotechmedics.com. No medical background is required for investors. A complete turnkey Pain Center development package is available.
BioTech Medics is an eleven-year-old company that has developed numerous sources of revenue including: a) sales of medical lasers; b) exclusive and proprietary high-powered therapeutic laser pain management medical protocol development and royalties; c) training and certification of laser technicians; d) the creation of BioTech pain management centers to be developed nationwide via licensing agreements, affiliation and/or franchises; e) products developed from 4 US Letters of Patent for SHBAN™ Antimicrobial Solution; and f) the sale of BioBody™ Nutriceutical Products.
Safe Harbor for Forward-Looking Statements.
This release contains forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995 (the "Act"). Such statements are subject to certain risks and uncertainties and actual results could differ materially from those expressed in any of the forward-looking statements.
Contact:
Investor Relations
972-274-5533
Life Vessel Newport Beach
949-222-9991 |
